Related content

Treatment of asymptomatic catecholaminergic polymorphic ventricular tachycardia

By Obeyesekere Manoj N   Sy Raymond W   Leong-Sit Peter   Gula Lorne J   Yee Raymond   Skanes Allan C   Klein George J   Krahn Andrew D  

Future Cardiology, Vol. 8, Iss. 3, 2012-05 ,pp. : 439-450

Future Medicine

Access to resources Recommend Favorite

Triple mode of action of flecainide in catecholaminergic polymorphic ventricular tachycardia

By Steele Derek S.   Hwang Hyun-Seok   Knollmann Björn C.  

Cardiovascular Research, Vol. 98, Iss. 2, 2013-05 ,pp. : 326-327

Oxford University Press

Access to resources Recommend Favorite

Triple mode of action of flecainide in catecholaminergic polymorphic ventricular tachycardia: reply

By Sikkel Markus B.   Collins Thomas P.   Rowlands Christina   Shah Mit   O'Gara Peter   Williams Alan J.   Harding Sian E.   Lyon Alexander R.   MacLeod Kenneth T.  

Cardiovascular Research, Vol. 98, Iss. 2, 2013-05 ,pp. : 327-328

Oxford University Press

Access to resources Recommend Favorite

A Missense Mutation in the CASQ2 Gene Is Associated with Autosomal-Recessive Catecholamine-Induced Polymorphic Ventricular Tachycardia

By Eldar M.   Pras E.   Lahat H.  

Trends in Cardiovascular Medicine, Vol. 13, Iss. 4, 2003-05 ,pp. : 148-151

Elsevier

Access to resources Recommend Favorite

Clinical effectiveness of pulmonary vein isolation for arrhythmic events in a patient with catecholaminergic polymorphic ventricular tachycardia

By Sumitomo Naokata   Nakamura Takahiro   Fukuhara Junji   Nakai Toshiko   Watanabe Ichiro   Mugishima Hideo   Hiraoka Masayasu  

Heart and Vessels, Vol. 25, Iss. 5, 2010-09 ,pp. : 448-452

Springer Publishing Company

Access to resources Recommend Favorite